Cargando…
Symptom evolution in the dying
OBJECTIVE: Provide insight in the prevalence of symptoms in patients who are in the last days of life. METHODS: A retrospective descriptive analysis of data on patients who died between 2012 and 2019 at the age of 18 or older in 1 of 20 Dutch healthcare facilities, including hospitals, inpatient hos...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985713/ https://www.ncbi.nlm.nih.gov/pubmed/36410945 http://dx.doi.org/10.1136/spcare-2022-003718 |
_version_ | 1784901015939579904 |
---|---|
author | Heijltjes, Madelon T van Zuylen, Lia van Thiel, Ghislaine JMW van Delden, Johannes JM van der Heide, Agnes |
author_facet | Heijltjes, Madelon T van Zuylen, Lia van Thiel, Ghislaine JMW van Delden, Johannes JM van der Heide, Agnes |
author_sort | Heijltjes, Madelon T |
collection | PubMed |
description | OBJECTIVE: Provide insight in the prevalence of symptoms in patients who are in the last days of life. METHODS: A retrospective descriptive analysis of data on patients who died between 2012 and 2019 at the age of 18 or older in 1 of 20 Dutch healthcare facilities, including hospitals, inpatient hospices and long-term care facilities. We analysed data from 4 hourly registrations in the Care Programme for the Dying Person, to assess for how many patients symptom-related goals of care were not achieved. We looked at the first 4 hours episode after the start of the Care Programme and the last 4 hours episode prior to death. RESULTS: We analysed records of 2786 patients. In the first 4 hours episode, at least one symptom-related care goal was not achieved for 28.5%–42.8% of patients, depending on the care setting. In the last 4 hours episode, these percentages were 17.5%–26.9%. Care goals concerning pain and restlessness were most often not achieved: percentages varied from 7.3% to 20.9% for pain and from 9.3% to 21.9% for restlessness. CONCLUSIONS: Symptom control at the end of life is not optimal in a substantial minority of patients. Systematic assessment and attention as well as further research on symptom management are of the essence. |
format | Online Article Text |
id | pubmed-9985713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-99857132023-03-06 Symptom evolution in the dying Heijltjes, Madelon T van Zuylen, Lia van Thiel, Ghislaine JMW van Delden, Johannes JM van der Heide, Agnes BMJ Support Palliat Care Short Report OBJECTIVE: Provide insight in the prevalence of symptoms in patients who are in the last days of life. METHODS: A retrospective descriptive analysis of data on patients who died between 2012 and 2019 at the age of 18 or older in 1 of 20 Dutch healthcare facilities, including hospitals, inpatient hospices and long-term care facilities. We analysed data from 4 hourly registrations in the Care Programme for the Dying Person, to assess for how many patients symptom-related goals of care were not achieved. We looked at the first 4 hours episode after the start of the Care Programme and the last 4 hours episode prior to death. RESULTS: We analysed records of 2786 patients. In the first 4 hours episode, at least one symptom-related care goal was not achieved for 28.5%–42.8% of patients, depending on the care setting. In the last 4 hours episode, these percentages were 17.5%–26.9%. Care goals concerning pain and restlessness were most often not achieved: percentages varied from 7.3% to 20.9% for pain and from 9.3% to 21.9% for restlessness. CONCLUSIONS: Symptom control at the end of life is not optimal in a substantial minority of patients. Systematic assessment and attention as well as further research on symptom management are of the essence. BMJ Publishing Group 2023-03 2022-11-21 /pmc/articles/PMC9985713/ /pubmed/36410945 http://dx.doi.org/10.1136/spcare-2022-003718 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Short Report Heijltjes, Madelon T van Zuylen, Lia van Thiel, Ghislaine JMW van Delden, Johannes JM van der Heide, Agnes Symptom evolution in the dying |
title | Symptom evolution in the dying |
title_full | Symptom evolution in the dying |
title_fullStr | Symptom evolution in the dying |
title_full_unstemmed | Symptom evolution in the dying |
title_short | Symptom evolution in the dying |
title_sort | symptom evolution in the dying |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985713/ https://www.ncbi.nlm.nih.gov/pubmed/36410945 http://dx.doi.org/10.1136/spcare-2022-003718 |
work_keys_str_mv | AT heijltjesmadelont symptomevolutioninthedying AT vanzuylenlia symptomevolutioninthedying AT vanthielghislainejmw symptomevolutioninthedying AT vandeldenjohannesjm symptomevolutioninthedying AT vanderheideagnes symptomevolutioninthedying |